Eagle Pharmaceuticals (EGRX) Tops Q3 EPS by 12c

November 9, 2016 6:51 AM EST
Get Alerts EGRX Hot Sheet
Trade EGRX Now!
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

Eagle Pharmaceuticals (NASDAQ: EGRX) reported Q3 EPS of $0.77, $0.12 better than the analyst estimate of $0.65. Revenue for the quarter came in at $37.8 million versus the consensus estimate of $41.04 million.

For earnings history and earnings-related data on Eagle Pharmaceuticals (EGRX) click here.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment